| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000036296 |
| Receipt No. | R000041351 |
| Scientific Title | A study about feeling of fatigue reduction effect of food containing algae |
| Date of disclosure of the study information | 2020/03/29 |
| Last modified on | 2021/08/24 (Ver. 7) |
| Basic information | ||
| Public title | A study about feeling of fatigue reduction effect of food containing algae | |
| Acronym | A study about feeling of fatigue reduction effect of food containing algae | |
| Scientific Title | A study about feeling of fatigue reduction effect of food containing algae | |
| Scientific Title:Acronym | A study about feeling of fatigue reduction effect of food containing algae | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to confirm feeling of fatigue reduction effect for four weeks continuous consumption of test food by comparison with control food. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | VAS questionnaire about feeling of fatigue (whole body feeling of fatigue, physical feeling of fatigue and psychological feeling of fatigue ) |
| Key secondary outcomes | *Profile of Mood States 2nd Edition
*The incidence of side effects and/or adverse events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake test food once a day at dinner time for 4 weeks. | |
| Interventions/Control_2 | Intake control food once a day at dinner time for 4 weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Healthy males and females aged 20 to 64 years old when consent acquisition.
2) Subjects who feel fatigue on daily basis. 3) Subjects who have received enough explanation about this study and were able to understand that, then giving written informed consent. |
|||
| Key exclusion criteria | 1) Subjects who have previous and/or current medical history of serious disease (e.g., heart function, blood vessel, liver function, kidney function, pulmonary function, endocrine function, function of digestive organ and/or metabolism).
2) Subjects who have been diagnosed chronic fatigue syndrome, or subjects who are decided having severe fatigue such as idiopathic chronic fatigue by investigator and/or sub-investigator. 3) Subjects who are visiting hospital due to chronic disease. 4) Subjects who have psychiatric disease such as depression and/or schizophrenia. 5) Subjects who have impairment of sleep which need medical treatment. 6) Subjects who are likely to cause allergies against test food especially algae and/or seaweeds. 7) Subjects who constantly use oral medicines and/or quasi-drug having the effect of recovering from fatigue or the effect of supplementation when physical fatigue. 8) Subjects who constantly use food with functional claim about feeling of fatigue. 9) Subjects who excessive alcohol intake. 10) Subjects their BMI is less than 17 kg/m2 or equal and more than 30 kg/m2. 11) Subjects who are participating the other clinical tests. Subjects who participated within three month prior to the current study and/or who plan to participate the other clinical tests. 12) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 13) Males who donated over 400mL blood and/or blood components within the last three month to the current study. 14) Females who donated over 400mL blood and/or blood components within the last four month to the current study. 15) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period. 16) Others who have been determined ineligible by principal investigator or sub-investigator. |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | CPCC Company Limited | ||||||
| Division name | Division of Clinical Research | ||||||
| Zip code | 101-0047 | ||||||
| Address | 4F Chusin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN | ||||||
| TEL | 03-5297-3112 | ||||||
| cpcc-contact@cpcc.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | CPCC Company Limited | ||||||
| Division name | Planning & Sales Department | ||||||
| Zip code | 101-0047 | ||||||
| Address | 4F Chusin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN | ||||||
| TEL | 03-5297-3112 | ||||||
| Homepage URL | |||||||
| cpcc-contact@cpcc.co.jp | |||||||
| Sponsor | |
| Institute | CPCC Company Limited |
| Institute | |
| Department | |
| Funding Source | |
| Organization | KOBELCO ECO-SOLUTIONS Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Chiyoda Paramedical Care Clinic |
| Address | 2F Chushin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, Japan |
| Tel | 03-5297-5548 |
| IRB@cpcc.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://www.pieronline.jp/content/article/0386-3603/47110/1851 |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | http://www.pieronline.jp/content/article/0386-3603/47110/1851 | ||||||
| Number of participants that the trial has enrolled | 200 | ||||||
| Results | A significant reduction in feeling of physical fatigue was confirmed in the test food intake group. | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Healthy males and females aged 20 to 64 years old | ||||||
| Participant flow | Completed (n=200)
Analysed (n=197) |
||||||
| Adverse events | No adverse events were observed that be related to test food. | ||||||
| Outcome measures | VAS questionnaire about feeling of fatigue | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041351 |